BFRIW (Biofrontera) PB Ratio: (As of Jun. 26, 2026)


BFRIW Biofrontera Inc BFRIW
44 GF Score
Price $0.06
! 4 Warning Signs
View Full Analysis

What is Biofrontera PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Biofrontera's share price is $0.063. Biofrontera's Book Value per Share for the quarter that ended in Mar. 2026 was $0.00. Hence, Biofrontera's PB Ratio of today is .

The historical rank and industry rank for Biofrontera's PB Ratio or its related term are showing as below:

BFRIW' s PB Ratio Range Over the Past 10 Years
Min: 0.23   Med: 1.57   Max: 16.04
Current: 1.96

During the past 7 years, Biofrontera's highest PB Ratio was 16.04. The lowest was 0.23. And the median was 1.57.

BFRIW's PB Ratio is ranked worse than
51.74% of 922 companies
in the Drug Manufacturers industry
Industry Median: 1.855 vs BFRIW: 1.96

During the past 12 months, Biofrontera's average Book Value Per Share Growth Rate was 864.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -63.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -49.50% per year.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Biofrontera was -33.20% per year. The lowest was -66.50% per year. And the median was -63.10% per year.

Back to Basics: PB Ratio


Biofrontera  (NAS:BFRIW) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Biofrontera PB Ratio Related Terms


Biofrontera PB Ratio Historical Data

* Premium members only.

The historical data trend for Biofrontera's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofrontera PB Ratio Chart

Biofrontera Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Biofrontera Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BFRIW vs AKAN, CABR, BIOE: PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biofrontera's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofrontera PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofrontera's PB Ratio distribution charts can be found below:

* The bar in red indicates where Biofrontera's PB Ratio falls into.


BFRIW
44GF Score
Biofrontera Inc BFRIW
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biofrontera PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Biofrontera's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=0.063/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Biofrontera Business Description

Other Exchanges BFRI:USA
Address 660 Main Street, 1st Floor, Woburn, MA, USA, 01801
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
44GF Score

Get the complete analysis for BFRIW

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.06
Price